Edwards Lifesciences stock upgraded to Market Perform by Bernstein
On Monday, Bernstein upgraded shares of Edwards Lifesciences (NYSE: NYSE:) from Underperform to Market Perform....
On Monday, Bernstein upgraded shares of Edwards Lifesciences (NYSE: NYSE:) from Underperform to Market Perform....
The lack of distributions is leading to a rise in continuation funds in private equity
"I wish I was, but they got that real wrong," Springsteen told The Telegraph.
New CEO Kelly Ortberg is grappling with a balance sheet strained by years of turmoil and the fallout from a strike, now in its seventh week.
By Jeslyn Lerh SINGAPORE (Reuters) – At one of the world’s biggest bulk export ports...
STOCKHOLM (Reuters) – Seven European countries have changed their laws to increase employee ownership in...
By Sakura Murakami, John Geddie and Tim Kelly TOKYO (Reuters) -Japan’s ruling coalition lost its...
Investing.com — In a research note this week, analysts at Bernstein highlighted 2030 as a...
By Jack Queen (Reuters) – Donald Trump’s Republican allies have suffered a string of courtroom...